nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—migraine—Prednisone—systemic scleroderma	0.202	0.508	CpDpCtD
Acetaminophen—osteoarthritis—Prednisone—systemic scleroderma	0.195	0.492	CpDpCtD
Acetaminophen—UGT1A6—Mycophenolic acid—systemic scleroderma	0.133	0.277	CbGbCtD
Acetaminophen—UGT1A10—Mycophenolate mofetil—systemic scleroderma	0.0862	0.179	CbGbCtD
Acetaminophen—UGT1A6—Mycophenolate mofetil—systemic scleroderma	0.0745	0.155	CbGbCtD
Acetaminophen—UGT1A9—Mycophenolic acid—systemic scleroderma	0.0389	0.0808	CbGbCtD
Acetaminophen—UGT1A1—Mycophenolic acid—systemic scleroderma	0.0318	0.0661	CbGbCtD
Acetaminophen—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.0217	0.0451	CbGbCtD
Acetaminophen—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0178	0.0369	CbGbCtD
Acetaminophen—CYP2C8—Mometasone—systemic scleroderma	0.0131	0.0272	CbGbCtD
Acetaminophen—SLC22A6—Captopril—systemic scleroderma	0.0101	0.0209	CbGbCtD
Acetaminophen—CYP1A2—Pentoxifylline—systemic scleroderma	0.00684	0.0142	CbGbCtD
Acetaminophen—CYP1A2—Leflunomide—systemic scleroderma	0.00653	0.0136	CbGbCtD
Acetaminophen—ABCB1—Lisinopril—systemic scleroderma	0.00598	0.0124	CbGbCtD
Acetaminophen—CYP2C9—Leflunomide—systemic scleroderma	0.00588	0.0122	CbGbCtD
Acetaminophen—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.00521	0.0108	CbGbCtD
Acetaminophen—ABCB1—Captopril—systemic scleroderma	0.00448	0.0093	CbGbCtD
Acetaminophen—CYP2D6—Captopril—systemic scleroderma	0.00422	0.00876	CbGbCtD
Acetaminophen—CYP2C9—cardial valve—systemic scleroderma	0.00419	0.172	CbGeAlD
Acetaminophen—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00353	0.00732	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—systemic scleroderma	0.00317	0.00659	CbGbCtD
Acetaminophen—ABCB1—Prednisone—systemic scleroderma	0.00282	0.00585	CbGbCtD
Acetaminophen—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00439	CbGbCtD
Acetaminophen—CYP3A4—Prednisone—systemic scleroderma	0.00169	0.00351	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—systemic scleroderma	0.00141	0.00294	CbGbCtD
Acetaminophen—PTGS2—skeletal joint—systemic scleroderma	0.00131	0.0537	CbGeAlD
Acetaminophen—UGT1A10—digestive system—systemic scleroderma	0.00125	0.0514	CbGeAlD
Acetaminophen—UGT1A6—digestive system—systemic scleroderma	0.00116	0.0478	CbGeAlD
Acetaminophen—SULT2A1—digestive system—systemic scleroderma	0.00108	0.0444	CbGeAlD
Acetaminophen—SULT1E1—digestive system—systemic scleroderma	0.000999	0.041	CbGeAlD
Acetaminophen—SULT1A1—digestive system—systemic scleroderma	0.00086	0.0353	CbGeAlD
Acetaminophen—SULT1E1—lung—systemic scleroderma	0.000835	0.0342	CbGeAlD
Acetaminophen—UGT2B15—digestive system—systemic scleroderma	0.00083	0.0341	CbGeAlD
Acetaminophen—SULT1A1—tendon—systemic scleroderma	0.000819	0.0336	CbGeAlD
Acetaminophen—CNR1—lung—systemic scleroderma	0.000781	0.032	CbGeAlD
Acetaminophen—TRPV1—digestive system—systemic scleroderma	0.000757	0.0311	CbGeAlD
Acetaminophen—SULT1A1—lung—systemic scleroderma	0.000719	0.0295	CbGeAlD
Acetaminophen—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000695	0.624	CbGdCrCtD
Acetaminophen—UGT1A9—digestive system—systemic scleroderma	0.000629	0.0258	CbGeAlD
Acetaminophen—PTGS1—artery—systemic scleroderma	0.000573	0.0235	CbGeAlD
Acetaminophen—PTGS2—artery—systemic scleroderma	0.000548	0.0225	CbGeAlD
Acetaminophen—PTGS1—endothelium—systemic scleroderma	0.000484	0.0199	CbGeAlD
Acetaminophen—PTGS2—endothelium—systemic scleroderma	0.000463	0.019	CbGeAlD
Acetaminophen—PTGS1—blood vessel—systemic scleroderma	0.000447	0.0183	CbGeAlD
Acetaminophen—UGT1A1—digestive system—systemic scleroderma	0.000431	0.0177	CbGeAlD
Acetaminophen—PTGS2—blood vessel—systemic scleroderma	0.000427	0.0175	CbGeAlD
Acetaminophen—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000419	0.376	CbGdCrCtD
Acetaminophen—CYP2A6—lung—systemic scleroderma	0.000303	0.0125	CbGeAlD
Acetaminophen—ABCB1—blood vessel—systemic scleroderma	0.000264	0.0108	CbGeAlD
Acetaminophen—CYP1A1—skin of body—systemic scleroderma	0.000235	0.00966	CbGeAlD
Acetaminophen—PTGS1—connective tissue—systemic scleroderma	0.000229	0.0094	CbGeAlD
Acetaminophen—PTGS2—connective tissue—systemic scleroderma	0.000219	0.00898	CbGeAlD
Acetaminophen—PTGS1—smooth muscle tissue—systemic scleroderma	0.00021	0.0086	CbGeAlD
Acetaminophen—PTGS1—skin of body—systemic scleroderma	0.000207	0.00849	CbGeAlD
Acetaminophen—PTGS2—smooth muscle tissue—systemic scleroderma	0.0002	0.00822	CbGeAlD
Acetaminophen—PTGS2—skin of body—systemic scleroderma	0.000198	0.00811	CbGeAlD
Acetaminophen—CYP1A2—digestive system—systemic scleroderma	0.000191	0.00783	CbGeAlD
Acetaminophen—CYP1A1—digestive system—systemic scleroderma	0.000188	0.00773	CbGeAlD
Acetaminophen—CYP2C9—digestive system—systemic scleroderma	0.000181	0.00743	CbGeAlD
Acetaminophen—CYP2E1—digestive system—systemic scleroderma	0.000172	0.00705	CbGeAlD
Acetaminophen—PTGS1—digestive system—systemic scleroderma	0.000165	0.00679	CbGeAlD
Acetaminophen—CYP2E1—tendon—systemic scleroderma	0.000163	0.0067	CbGeAlD
Acetaminophen—CYP1A2—lung—systemic scleroderma	0.000159	0.00654	CbGeAlD
Acetaminophen—PTGS2—digestive system—systemic scleroderma	0.000158	0.00649	CbGeAlD
Acetaminophen—PTGS1—tendon—systemic scleroderma	0.000157	0.00646	CbGeAlD
Acetaminophen—CYP1A1—lung—systemic scleroderma	0.000157	0.00645	CbGeAlD
Acetaminophen—PTGS2—tendon—systemic scleroderma	0.00015	0.00617	CbGeAlD
Acetaminophen—CYP2E1—lung—systemic scleroderma	0.000143	0.00588	CbGeAlD
Acetaminophen—CYP3A4—digestive system—systemic scleroderma	0.000138	0.00567	CbGeAlD
Acetaminophen—PTGS1—lung—systemic scleroderma	0.000138	0.00567	CbGeAlD
Acetaminophen—CYP2D6—digestive system—systemic scleroderma	0.000136	0.00558	CbGeAlD
Acetaminophen—PTGS2—lung—systemic scleroderma	0.000132	0.00542	CbGeAlD
Acetaminophen—ABCB1—digestive system—systemic scleroderma	9.78e-05	0.00401	CbGeAlD
Acetaminophen—Anaemia—Mycophenolate mofetil—systemic scleroderma	8.43e-05	0.000874	CcSEcCtD
Acetaminophen—Dyspnoea—Mycophenolic acid—systemic scleroderma	8.41e-05	0.000872	CcSEcCtD
Acetaminophen—Somnolence—Mycophenolic acid—systemic scleroderma	8.38e-05	0.00087	CcSEcCtD
Acetaminophen—Agitation—Mycophenolate mofetil—systemic scleroderma	8.38e-05	0.000869	CcSEcCtD
Acetaminophen—Shock—Lisinopril—systemic scleroderma	8.36e-05	0.000867	CcSEcCtD
Acetaminophen—Angioedema—Mycophenolate mofetil—systemic scleroderma	8.33e-05	0.000864	CcSEcCtD
Acetaminophen—Thrombocytopenia—Lisinopril—systemic scleroderma	8.32e-05	0.000863	CcSEcCtD
Acetaminophen—Dyspepsia—Mycophenolic acid—systemic scleroderma	8.3e-05	0.000861	CcSEcCtD
Acetaminophen—Neutropenia—Prednisone—systemic scleroderma	8.29e-05	0.000861	CcSEcCtD
Acetaminophen—Tachycardia—Lisinopril—systemic scleroderma	8.29e-05	0.00086	CcSEcCtD
Acetaminophen—Body temperature increased—Azathioprine—systemic scleroderma	8.27e-05	0.000858	CcSEcCtD
Acetaminophen—Abdominal pain—Azathioprine—systemic scleroderma	8.27e-05	0.000858	CcSEcCtD
Acetaminophen—Skin disorder—Lisinopril—systemic scleroderma	8.25e-05	0.000856	CcSEcCtD
Acetaminophen—Malaise—Mycophenolate mofetil—systemic scleroderma	8.22e-05	0.000853	CcSEcCtD
Acetaminophen—Hyperhidrosis—Lisinopril—systemic scleroderma	8.21e-05	0.000852	CcSEcCtD
Acetaminophen—Diarrhoea—Captopril—systemic scleroderma	8.21e-05	0.000851	CcSEcCtD
Acetaminophen—Decreased appetite—Mycophenolic acid—systemic scleroderma	8.2e-05	0.00085	CcSEcCtD
Acetaminophen—Irritability—Methotrexate—systemic scleroderma	8.19e-05	0.000849	CcSEcCtD
Acetaminophen—ABCB1—lung—systemic scleroderma	8.17e-05	0.00335	CbGeAlD
Acetaminophen—Leukopenia—Mycophenolate mofetil—systemic scleroderma	8.16e-05	0.000847	CcSEcCtD
Acetaminophen—Feeling abnormal—Leflunomide—systemic scleroderma	8.14e-05	0.000845	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	8.14e-05	0.000845	CcSEcCtD
Acetaminophen—Fatigue—Mycophenolic acid—systemic scleroderma	8.13e-05	0.000844	CcSEcCtD
Acetaminophen—Nausea—Mometasone—systemic scleroderma	8.11e-05	0.000842	CcSEcCtD
Acetaminophen—Anorexia—Lisinopril—systemic scleroderma	8.1e-05	0.00084	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Leflunomide—systemic scleroderma	8.08e-05	0.000839	CcSEcCtD
Acetaminophen—Constipation—Mycophenolic acid—systemic scleroderma	8.06e-05	0.000837	CcSEcCtD
Acetaminophen—Palpitations—Mycophenolate mofetil—systemic scleroderma	8.06e-05	0.000836	CcSEcCtD
Acetaminophen—Hyperglycaemia—Prednisone—systemic scleroderma	8e-05	0.00083	CcSEcCtD
Acetaminophen—Cough—Mycophenolate mofetil—systemic scleroderma	7.96e-05	0.000826	CcSEcCtD
Acetaminophen—Hypotension—Lisinopril—systemic scleroderma	7.94e-05	0.000823	CcSEcCtD
Acetaminophen—Dizziness—Captopril—systemic scleroderma	7.93e-05	0.000823	CcSEcCtD
Acetaminophen—Convulsion—Mycophenolate mofetil—systemic scleroderma	7.9e-05	0.00082	CcSEcCtD
Acetaminophen—Hypertension—Mycophenolate mofetil—systemic scleroderma	7.87e-05	0.000817	CcSEcCtD
Acetaminophen—Urticaria—Leflunomide—systemic scleroderma	7.85e-05	0.000815	CcSEcCtD
Acetaminophen—Body temperature increased—Leflunomide—systemic scleroderma	7.81e-05	0.000811	CcSEcCtD
Acetaminophen—Abdominal pain—Leflunomide—systemic scleroderma	7.81e-05	0.000811	CcSEcCtD
Acetaminophen—Feeling abnormal—Mycophenolic acid—systemic scleroderma	7.77e-05	0.000806	CcSEcCtD
Acetaminophen—Chest pain—Mycophenolate mofetil—systemic scleroderma	7.76e-05	0.000805	CcSEcCtD
Acetaminophen—Anxiety—Mycophenolate mofetil—systemic scleroderma	7.74e-05	0.000803	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	7.72e-05	0.000801	CcSEcCtD
Acetaminophen—Hypersensitivity—Azathioprine—systemic scleroderma	7.71e-05	0.0008	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.71e-05	0.0008	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	7.71e-05	0.0008	CcSEcCtD
Acetaminophen—Insomnia—Lisinopril—systemic scleroderma	7.68e-05	0.000797	CcSEcCtD
Acetaminophen—Discomfort—Mycophenolate mofetil—systemic scleroderma	7.67e-05	0.000796	CcSEcCtD
Acetaminophen—Vomiting—Captopril—systemic scleroderma	7.62e-05	0.000791	CcSEcCtD
Acetaminophen—Dry mouth—Mycophenolate mofetil—systemic scleroderma	7.59e-05	0.000788	CcSEcCtD
Acetaminophen—Dyspnoea—Lisinopril—systemic scleroderma	7.57e-05	0.000786	CcSEcCtD
Acetaminophen—Rash—Captopril—systemic scleroderma	7.56e-05	0.000785	CcSEcCtD
Acetaminophen—Dermatitis—Captopril—systemic scleroderma	7.55e-05	0.000784	CcSEcCtD
Acetaminophen—Somnolence—Lisinopril—systemic scleroderma	7.55e-05	0.000783	CcSEcCtD
Acetaminophen—Headache—Captopril—systemic scleroderma	7.51e-05	0.00078	CcSEcCtD
Acetaminophen—Confusional state—Mycophenolate mofetil—systemic scleroderma	7.5e-05	0.000779	CcSEcCtD
Acetaminophen—Dyspepsia—Lisinopril—systemic scleroderma	7.48e-05	0.000776	CcSEcCtD
Acetaminophen—Abdominal pain—Mycophenolic acid—systemic scleroderma	7.45e-05	0.000773	CcSEcCtD
Acetaminophen—Body temperature increased—Mycophenolic acid—systemic scleroderma	7.45e-05	0.000773	CcSEcCtD
Acetaminophen—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	7.44e-05	0.000772	CcSEcCtD
Acetaminophen—Oedema—Mycophenolate mofetil—systemic scleroderma	7.44e-05	0.000772	CcSEcCtD
Acetaminophen—Asthma—Methotrexate—systemic scleroderma	7.41e-05	0.000769	CcSEcCtD
Acetaminophen—Decreased appetite—Lisinopril—systemic scleroderma	7.38e-05	0.000766	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Lisinopril—systemic scleroderma	7.33e-05	0.000761	CcSEcCtD
Acetaminophen—Fatigue—Lisinopril—systemic scleroderma	7.32e-05	0.00076	CcSEcCtD
Acetaminophen—Shock—Mycophenolate mofetil—systemic scleroderma	7.32e-05	0.00076	CcSEcCtD
Acetaminophen—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	7.3e-05	0.000757	CcSEcCtD
Acetaminophen—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	7.29e-05	0.000756	CcSEcCtD
Acetaminophen—Hypersensitivity—Leflunomide—systemic scleroderma	7.28e-05	0.000756	CcSEcCtD
Acetaminophen—Constipation—Lisinopril—systemic scleroderma	7.26e-05	0.000754	CcSEcCtD
Acetaminophen—Tachycardia—Mycophenolate mofetil—systemic scleroderma	7.26e-05	0.000754	CcSEcCtD
Acetaminophen—Skin disorder—Mycophenolate mofetil—systemic scleroderma	7.23e-05	0.00075	CcSEcCtD
Acetaminophen—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	7.19e-05	0.000746	CcSEcCtD
Acetaminophen—Diarrhoea—Azathioprine—systemic scleroderma	7.16e-05	0.000743	CcSEcCtD
Acetaminophen—Haemoglobin—Prednisone—systemic scleroderma	7.14e-05	0.00074	CcSEcCtD
Acetaminophen—Nausea—Captopril—systemic scleroderma	7.12e-05	0.000739	CcSEcCtD
Acetaminophen—Abdominal discomfort—Methotrexate—systemic scleroderma	7.11e-05	0.000737	CcSEcCtD
Acetaminophen—Haemorrhage—Prednisone—systemic scleroderma	7.1e-05	0.000737	CcSEcCtD
Acetaminophen—Anorexia—Mycophenolate mofetil—systemic scleroderma	7.09e-05	0.000736	CcSEcCtD
Acetaminophen—Asthenia—Leflunomide—systemic scleroderma	7.09e-05	0.000736	CcSEcCtD
Acetaminophen—Hallucination—Prednisone—systemic scleroderma	7.06e-05	0.000733	CcSEcCtD
Acetaminophen—Pancytopenia—Methotrexate—systemic scleroderma	7.04e-05	0.00073	CcSEcCtD
Acetaminophen—Feeling abnormal—Lisinopril—systemic scleroderma	7e-05	0.000726	CcSEcCtD
Acetaminophen—Pruritus—Leflunomide—systemic scleroderma	6.99e-05	0.000726	CcSEcCtD
Acetaminophen—Connective tissue disorder—Prednisone—systemic scleroderma	6.98e-05	0.000724	CcSEcCtD
Acetaminophen—Hypotension—Mycophenolate mofetil—systemic scleroderma	6.95e-05	0.000721	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Lisinopril—systemic scleroderma	6.94e-05	0.000721	CcSEcCtD
Acetaminophen—Dysuria—Methotrexate—systemic scleroderma	6.93e-05	0.000719	CcSEcCtD
Acetaminophen—Neutropenia—Methotrexate—systemic scleroderma	6.93e-05	0.000719	CcSEcCtD
Acetaminophen—Dizziness—Azathioprine—systemic scleroderma	6.92e-05	0.000718	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Methotrexate—systemic scleroderma	6.77e-05	0.000702	CcSEcCtD
Acetaminophen—Asthenia—Mycophenolic acid—systemic scleroderma	6.76e-05	0.000702	CcSEcCtD
Acetaminophen—Diarrhoea—Leflunomide—systemic scleroderma	6.76e-05	0.000702	CcSEcCtD
Acetaminophen—Urticaria—Lisinopril—systemic scleroderma	6.75e-05	0.0007	CcSEcCtD
Acetaminophen—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.73e-05	0.000698	CcSEcCtD
Acetaminophen—Abdominal pain—Lisinopril—systemic scleroderma	6.71e-05	0.000697	CcSEcCtD
Acetaminophen—Body temperature increased—Lisinopril—systemic scleroderma	6.71e-05	0.000697	CcSEcCtD
Acetaminophen—Pruritus—Mycophenolic acid—systemic scleroderma	6.67e-05	0.000692	CcSEcCtD
Acetaminophen—Vomiting—Azathioprine—systemic scleroderma	6.65e-05	0.00069	CcSEcCtD
Acetaminophen—Eye disorder—Prednisone—systemic scleroderma	6.63e-05	0.000688	CcSEcCtD
Acetaminophen—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.63e-05	0.000688	CcSEcCtD
Acetaminophen—Somnolence—Mycophenolate mofetil—systemic scleroderma	6.62e-05	0.000686	CcSEcCtD
Acetaminophen—Drowsiness—Methotrexate—systemic scleroderma	6.61e-05	0.000686	CcSEcCtD
Acetaminophen—Rash—Azathioprine—systemic scleroderma	6.6e-05	0.000685	CcSEcCtD
Acetaminophen—Dermatitis—Azathioprine—systemic scleroderma	6.59e-05	0.000684	CcSEcCtD
Acetaminophen—Flushing—Prednisone—systemic scleroderma	6.59e-05	0.000684	CcSEcCtD
Acetaminophen—Headache—Azathioprine—systemic scleroderma	6.56e-05	0.00068	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	6.55e-05	0.00068	CcSEcCtD
Acetaminophen—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	6.55e-05	0.00068	CcSEcCtD
Acetaminophen—Dizziness—Leflunomide—systemic scleroderma	6.54e-05	0.000678	CcSEcCtD
Acetaminophen—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	6.47e-05	0.000671	CcSEcCtD
Acetaminophen—Diarrhoea—Mycophenolic acid—systemic scleroderma	6.45e-05	0.000669	CcSEcCtD
Acetaminophen—Angiopathy—Prednisone—systemic scleroderma	6.44e-05	0.000668	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	6.42e-05	0.000667	CcSEcCtD
Acetaminophen—Immune system disorder—Prednisone—systemic scleroderma	6.41e-05	0.000665	CcSEcCtD
Acetaminophen—Constipation—Mycophenolate mofetil—systemic scleroderma	6.36e-05	0.00066	CcSEcCtD
Acetaminophen—Sweating—Methotrexate—systemic scleroderma	6.34e-05	0.000657	CcSEcCtD
Acetaminophen—Vomiting—Leflunomide—systemic scleroderma	6.28e-05	0.000652	CcSEcCtD
Acetaminophen—Hypersensitivity—Lisinopril—systemic scleroderma	6.26e-05	0.000649	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—systemic scleroderma	6.25e-05	0.000649	CcSEcCtD
Acetaminophen—Dizziness—Mycophenolic acid—systemic scleroderma	6.24e-05	0.000647	CcSEcCtD
Acetaminophen—Rash—Leflunomide—systemic scleroderma	6.23e-05	0.000647	CcSEcCtD
Acetaminophen—Dermatitis—Leflunomide—systemic scleroderma	6.23e-05	0.000646	CcSEcCtD
Acetaminophen—Mental disorder—Prednisone—systemic scleroderma	6.22e-05	0.000645	CcSEcCtD
Acetaminophen—Nausea—Azathioprine—systemic scleroderma	6.22e-05	0.000645	CcSEcCtD
Acetaminophen—Headache—Leflunomide—systemic scleroderma	6.19e-05	0.000642	CcSEcCtD
Acetaminophen—Erythema—Prednisone—systemic scleroderma	6.18e-05	0.000641	CcSEcCtD
Acetaminophen—Malnutrition—Prednisone—systemic scleroderma	6.18e-05	0.000641	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—systemic scleroderma	6.17e-05	0.00064	CcSEcCtD
Acetaminophen—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	6.13e-05	0.000636	CcSEcCtD
Acetaminophen—Asthenia—Lisinopril—systemic scleroderma	6.09e-05	0.000632	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	6.08e-05	0.000631	CcSEcCtD
Acetaminophen—Pruritus—Lisinopril—systemic scleroderma	6.01e-05	0.000623	CcSEcCtD
Acetaminophen—Vomiting—Mycophenolic acid—systemic scleroderma	5.99e-05	0.000622	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—systemic scleroderma	5.96e-05	0.000619	CcSEcCtD
Acetaminophen—Rash—Mycophenolic acid—systemic scleroderma	5.95e-05	0.000617	CcSEcCtD
Acetaminophen—Dermatitis—Mycophenolic acid—systemic scleroderma	5.94e-05	0.000616	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—systemic scleroderma	5.93e-05	0.000616	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—systemic scleroderma	5.93e-05	0.000616	CcSEcCtD
Acetaminophen—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.91e-05	0.000613	CcSEcCtD
Acetaminophen—Headache—Mycophenolic acid—systemic scleroderma	5.91e-05	0.000613	CcSEcCtD
Acetaminophen—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	5.88e-05	0.00061	CcSEcCtD
Acetaminophen—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	5.88e-05	0.00061	CcSEcCtD
Acetaminophen—Nausea—Leflunomide—systemic scleroderma	5.87e-05	0.000609	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—systemic scleroderma	5.86e-05	0.000608	CcSEcCtD
Acetaminophen—Vision blurred—Prednisone—systemic scleroderma	5.82e-05	0.000604	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—systemic scleroderma	5.82e-05	0.000604	CcSEcCtD
Acetaminophen—Diarrhoea—Lisinopril—systemic scleroderma	5.81e-05	0.000603	CcSEcCtD
Acetaminophen—Ill-defined disorder—Prednisone—systemic scleroderma	5.73e-05	0.000595	CcSEcCtD
Acetaminophen—Anaemia—Prednisone—systemic scleroderma	5.71e-05	0.000593	CcSEcCtD
Acetaminophen—Agitation—Prednisone—systemic scleroderma	5.68e-05	0.000589	CcSEcCtD
Acetaminophen—Angioedema—Prednisone—systemic scleroderma	5.65e-05	0.000586	CcSEcCtD
Acetaminophen—Dizziness—Lisinopril—systemic scleroderma	5.62e-05	0.000583	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—systemic scleroderma	5.61e-05	0.000582	CcSEcCtD
Acetaminophen—Nausea—Mycophenolic acid—systemic scleroderma	5.6e-05	0.000581	CcSEcCtD
Acetaminophen—Malaise—Prednisone—systemic scleroderma	5.57e-05	0.000578	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—systemic scleroderma	5.54e-05	0.000575	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—systemic scleroderma	5.51e-05	0.000571	CcSEcCtD
Acetaminophen—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.48e-05	0.000569	CcSEcCtD
Acetaminophen—Vomiting—Lisinopril—systemic scleroderma	5.4e-05	0.00056	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—systemic scleroderma	5.38e-05	0.000559	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—systemic scleroderma	5.36e-05	0.000556	CcSEcCtD
Acetaminophen—Rash—Lisinopril—systemic scleroderma	5.35e-05	0.000556	CcSEcCtD
Acetaminophen—Convulsion—Prednisone—systemic scleroderma	5.35e-05	0.000556	CcSEcCtD
Acetaminophen—Dermatitis—Lisinopril—systemic scleroderma	5.35e-05	0.000555	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—systemic scleroderma	5.35e-05	0.000555	CcSEcCtD
Acetaminophen—Asthenia—Mycophenolate mofetil—systemic scleroderma	5.34e-05	0.000554	CcSEcCtD
Acetaminophen—Hypertension—Prednisone—systemic scleroderma	5.34e-05	0.000554	CcSEcCtD
Acetaminophen—Chills—Methotrexate—systemic scleroderma	5.32e-05	0.000552	CcSEcCtD
Acetaminophen—Headache—Lisinopril—systemic scleroderma	5.32e-05	0.000552	CcSEcCtD
Acetaminophen—Pruritus—Mycophenolate mofetil—systemic scleroderma	5.26e-05	0.000546	CcSEcCtD
Acetaminophen—Anxiety—Prednisone—systemic scleroderma	5.24e-05	0.000544	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	5.23e-05	0.000542	CcSEcCtD
Acetaminophen—Discomfort—Prednisone—systemic scleroderma	5.2e-05	0.000539	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—systemic scleroderma	5.2e-05	0.000539	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—systemic scleroderma	5.17e-05	0.000536	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—systemic scleroderma	5.17e-05	0.000536	CcSEcCtD
Acetaminophen—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.09e-05	0.000528	CcSEcCtD
Acetaminophen—Nausea—Lisinopril—systemic scleroderma	5.04e-05	0.000523	CcSEcCtD
Acetaminophen—Anaphylactic shock—Prednisone—systemic scleroderma	5.04e-05	0.000523	CcSEcCtD
Acetaminophen—Oedema—Prednisone—systemic scleroderma	5.04e-05	0.000523	CcSEcCtD
Acetaminophen—Shock—Prednisone—systemic scleroderma	4.96e-05	0.000515	CcSEcCtD
Acetaminophen—Nervous system disorder—Prednisone—systemic scleroderma	4.95e-05	0.000513	CcSEcCtD
Acetaminophen—Tachycardia—Prednisone—systemic scleroderma	4.92e-05	0.000511	CcSEcCtD
Acetaminophen—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.92e-05	0.000511	CcSEcCtD
Acetaminophen—Skin disorder—Prednisone—systemic scleroderma	4.9e-05	0.000508	CcSEcCtD
Acetaminophen—Hyperhidrosis—Prednisone—systemic scleroderma	4.88e-05	0.000506	CcSEcCtD
Acetaminophen—Vision blurred—Methotrexate—systemic scleroderma	4.87e-05	0.000505	CcSEcCtD
Acetaminophen—Anorexia—Prednisone—systemic scleroderma	4.81e-05	0.000499	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—systemic scleroderma	4.79e-05	0.000497	CcSEcCtD
Acetaminophen—Anaemia—Methotrexate—systemic scleroderma	4.77e-05	0.000495	CcSEcCtD
Acetaminophen—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.73e-05	0.000491	CcSEcCtD
Acetaminophen—Rash—Mycophenolate mofetil—systemic scleroderma	4.69e-05	0.000487	CcSEcCtD
Acetaminophen—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.69e-05	0.000486	CcSEcCtD
Acetaminophen—Headache—Mycophenolate mofetil—systemic scleroderma	4.66e-05	0.000484	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—systemic scleroderma	4.66e-05	0.000483	CcSEcCtD
Acetaminophen—Leukopenia—Methotrexate—systemic scleroderma	4.62e-05	0.00048	CcSEcCtD
Acetaminophen—Insomnia—Prednisone—systemic scleroderma	4.56e-05	0.000473	CcSEcCtD
Acetaminophen—Cough—Methotrexate—systemic scleroderma	4.51e-05	0.000468	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—systemic scleroderma	4.48e-05	0.000464	CcSEcCtD
Acetaminophen—Dyspepsia—Prednisone—systemic scleroderma	4.44e-05	0.000461	CcSEcCtD
Acetaminophen—Nausea—Mycophenolate mofetil—systemic scleroderma	4.42e-05	0.000459	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—systemic scleroderma	4.4e-05	0.000456	CcSEcCtD
Acetaminophen—Decreased appetite—Prednisone—systemic scleroderma	4.38e-05	0.000455	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	4.37e-05	0.000453	CcSEcCtD
Acetaminophen—Fatigue—Prednisone—systemic scleroderma	4.35e-05	0.000451	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—systemic scleroderma	4.34e-05	0.000451	CcSEcCtD
Acetaminophen—Constipation—Prednisone—systemic scleroderma	4.31e-05	0.000448	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—systemic scleroderma	4.25e-05	0.000441	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—systemic scleroderma	4.22e-05	0.000437	CcSEcCtD
Acetaminophen—Feeling abnormal—Prednisone—systemic scleroderma	4.16e-05	0.000431	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—systemic scleroderma	4.13e-05	0.000429	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—systemic scleroderma	4.13e-05	0.000428	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Prednisone—systemic scleroderma	4.12e-05	0.000428	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—systemic scleroderma	4.09e-05	0.000425	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—systemic scleroderma	4.08e-05	0.000423	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—systemic scleroderma	4.02e-05	0.000417	CcSEcCtD
Acetaminophen—Urticaria—Prednisone—systemic scleroderma	4.01e-05	0.000416	CcSEcCtD
Acetaminophen—Abdominal pain—Prednisone—systemic scleroderma	3.99e-05	0.000414	CcSEcCtD
Acetaminophen—Body temperature increased—Prednisone—systemic scleroderma	3.99e-05	0.000414	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—systemic scleroderma	3.94e-05	0.000409	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—systemic scleroderma	3.81e-05	0.000396	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—systemic scleroderma	3.76e-05	0.00039	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—systemic scleroderma	3.75e-05	0.000389	CcSEcCtD
Acetaminophen—Hypersensitivity—Prednisone—systemic scleroderma	3.72e-05	0.000386	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—systemic scleroderma	3.71e-05	0.000385	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—systemic scleroderma	3.66e-05	0.00038	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.64e-05	0.000378	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—systemic scleroderma	3.63e-05	0.000377	CcSEcCtD
Acetaminophen—Asthenia—Prednisone—systemic scleroderma	3.62e-05	0.000376	CcSEcCtD
Acetaminophen—Pruritus—Prednisone—systemic scleroderma	3.57e-05	0.00037	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—systemic scleroderma	3.47e-05	0.00036	CcSEcCtD
Acetaminophen—Diarrhoea—Prednisone—systemic scleroderma	3.45e-05	0.000358	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.45e-05	0.000358	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—systemic scleroderma	3.35e-05	0.000347	CcSEcCtD
Acetaminophen—Dizziness—Prednisone—systemic scleroderma	3.34e-05	0.000346	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—systemic scleroderma	3.33e-05	0.000346	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—systemic scleroderma	3.33e-05	0.000346	CcSEcCtD
Acetaminophen—Vomiting—Prednisone—systemic scleroderma	3.21e-05	0.000333	CcSEcCtD
Acetaminophen—Rash—Prednisone—systemic scleroderma	3.18e-05	0.00033	CcSEcCtD
Acetaminophen—Dermatitis—Prednisone—systemic scleroderma	3.18e-05	0.00033	CcSEcCtD
Acetaminophen—Headache—Prednisone—systemic scleroderma	3.16e-05	0.000328	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—systemic scleroderma	3.11e-05	0.000322	CcSEcCtD
Acetaminophen—Asthenia—Methotrexate—systemic scleroderma	3.02e-05	0.000314	CcSEcCtD
Acetaminophen—Nausea—Prednisone—systemic scleroderma	3e-05	0.000311	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—systemic scleroderma	2.98e-05	0.000309	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—systemic scleroderma	2.88e-05	0.000299	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—systemic scleroderma	2.79e-05	0.000289	CcSEcCtD
Acetaminophen—Vomiting—Methotrexate—systemic scleroderma	2.68e-05	0.000278	CcSEcCtD
Acetaminophen—Rash—Methotrexate—systemic scleroderma	2.66e-05	0.000276	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—systemic scleroderma	2.66e-05	0.000276	CcSEcCtD
Acetaminophen—Headache—Methotrexate—systemic scleroderma	2.64e-05	0.000274	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—systemic scleroderma	2.5e-05	0.00026	CcSEcCtD
